1-7 of 7
Giorgio Priolo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Centralized MRD Assessment at Early Timepoints in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk AML

Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paola Paoloni, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto M. Lemoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1567.
https://doi.org/10.1182/blood-2023-189777
Published: 2023
Journal Articles

Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Roberto Massimo Lemoli, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo G. Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Fabio Guolo, Edoardo La Sala, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 1705–1707.
https://doi.org/10.1182/blood-2022-157393
Published: 2022
Journal Articles

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Clinical Trials & Observations
Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Barbara Botto, Simone Ferrero, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Giorgio Limerutti, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Roberto Passera, Gianni Bisi, Umberto Vitolo
Journal: Blood
Blood (2012) 119 (9): 2066–2073.
https://doi.org/10.1182/blood-2011-06-359943
Published: 2012
Journal Articles

Retrospective Analysis of 206 Mantle Cell Lymphoma Patients at Diagnosis: Mantle Cell International Prognostic Index (MIPI) Is a Good Predictor of Death Event In Patients Treated Either with Rituximab-Chemotherapy or Rituximab-High-Dose-Chemotherapy

Annalisa Chiappella, Benedetta Puccini, Simone Ferrero, Luca Arcaini, Ileana Baldi, Giulia Benevolo, Carola Boccomini, Barbara Botto, Chiara Ciochetto, Sergio Cortelazzo, Alberto Fabbri, Chiara Frairia, Cristina Gabutti, Marco Ladetto, Michael Mian, Domenico Novero, Lorella Orsucci, Patrizia Pregno, Giorgio Priolo, Luigi Rigacci, Marianna Rossi, Chiara Rusconi, Umberto Vitolo
Journal: Blood
Blood (2010) 116 (21): 1784.
https://doi.org/10.1182/blood.V116.21.1784.1784
Published: 2010
Journal Articles

The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy.

Umberto Vitolo, Annalisa Chiappella, Marilena Bellò, Roberto Passera, Barbara Botto, Giancarlo Castellano, Chiara Ciochetto, Simone Ferrero, Chiara Frairia, Silvia Franceschetti, Francesca Giunta, Marco Ladetto, Massimo Menga, Maura Nicolosi, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Luca Vaggelli, Patrizia Pregno, Gianni Bisi
Journal: Blood
Blood (2010) 116 (21): 2819.
https://doi.org/10.1182/blood.V116.21.2819.2819
Published: 2010
Journal Articles

Interim 18-FDG-Positron Emission Tomography/Computed Tomography (PET) Failed to Predict Different Outcome in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab-CHOP.

Patrizia Pregno, Annalisa Chiappella, Marilena Bellò, Roberto Passera, Simone Ferrero, Giulia Benevolo, Carola Boccomini, Giancarlo Castellano, Silvia Franceschetti, Massimo Menga, Lorella Orsucci, Giorgio Priolo, Benedetta Puccini, Luigi Rigacci, Flavia Salvi, Marco Ladetto, Umberto Vitolo
Journal: Blood
Blood (2009) 114 (22): 99.
https://doi.org/10.1182/blood.V114.22.99.99
Published: 2009
Journal Articles

Mantle Cell International Prognostic Index (MIPI) Is a Strong Predictor of the Outcome of Mantle Cell Lymphoma (MCL) in the Rituximab (R) Era.

Annalisa Chiappella, Benedetta Puccini, Marianna Rossi, Simone Ferrero, Luca Arcaini, Ernesta Audisio, Ileana Baldi, Carola Boccomini, Barbara Botto, Fabbri Alberto, Chiara Frairia, Roberto Freilone, Marco Ladetto, Domenico Novero, Marco Paulli, Patrizia Pregno, Giorgio Priolo, Luigi Rigacci, Umberto Vitolo
Journal: Blood
Blood (2009) 114 (22): 2928.
https://doi.org/10.1182/blood.V114.22.2928.2928
Published: 2009